Who owns KYNTRA BIO, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of KYNB from SEC Form 13F filings across 27 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 27 institutions disclosed 998,990 shares of KYNTRA BIO, INC. worth $7.5M — about 24.7% of shares outstanding; the largest disclosed holder is ARMISTICE CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
27
13F holders
$7.5M
value, 2026 filers
24.7%
of shares outstanding (998,990 sh)
1
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of KYNB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 400,000 | $3.0M | 0.0% | 9.9% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 159,950 | $1.2M | 0.0% | 4% | +2.1% |
| 3 | ACADIAN ASSET MANAGEMENT LLC | 105,585 | $795,000 | 0.0% | 2.6% | 0.0% |
| 4 | BlackRock, Inc. | 84,330 | $636,692 | 0.0% | 2.1% | 0.0% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 43,219 | $326,385 | 0.0% | 1.1% | -6.0% |
| 6 | HighTower Advisors, LLC | 39,746 | $300,082 | 0.0% | 1% | 0.0% |
| 7 | TWO SIGMA INVESTMENTS, LP | 39,511 | $298,308 | 0.0% | 1% | -20.2% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 27,081 | $204,462 | 0.0% | 0.7% | -1.5% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 24,105 | $181,993 | 0.0% | 0.6% | +0.7% |
| 10 | Birchview Capital, LP | 22,566 | $170,373 | 0.1% | 0.6% | 0.0% |
| 11 | STATE STREET CORP | 20,284 | $153,144 | 0.0% | 0.5% | 0.0% |
| 12 | GSA CAPITAL PARTNERS LLPNEW | 15,697 | $119,000 | 0.0% | 0.4% | new |
| 13 | UBS Group AG | 7,857 | $59,320 | 0.0% | 0.2% | -71.5% |
| 14 | GROUP ONE TRADING LLC | 4,406 | $33,265 | 0.0% | 0.1% | -1.9% |
| 15 | Vanguard Global Advisers, LLC | 1,424 | $10,751 | 0.0% | 0% | 0.0% |
| 16 | Tower Research Capital LLC (TRC) | 1,113 | $8,403 | 0.0% | 0% | +235.2% |
| 17 | Axiom Investment Management LLC | 704 | $5,315 | 0.0% | 0% | 0.0% |
| 18 | MORGAN STANLEY | 487 | $3,677 | 0.0% | 0% | -0.2% |
| 19 | HARBOUR INVESTMENTS, INC. | 200 | $1,510 | 0.0% | 0% | 0.0% |
| 20 | NATIONAL BANK OF CANADA /FI/ | 193 | $1,448 | 0.0% | 0% | 0.0% |
| 21 | OSAIC HOLDINGS, INC. | 182 | $1,374 | 0.0% | 0% | +1.1% |
| 22 | SBI Securities Co., Ltd. | 152 | $1,148 | 0.0% | 0% | 0.0% |
| 23 | ROYAL BANK OF CANADA | 138 | $1,000 | 0.0% | 0% | +0.7% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 46 | $347 | 0.0% | 0% | -8.0% |
| 25 | JPMORGAN CHASE & CO | 12 | $88 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.